Thucanh Multerer, MD
Retina Specialist · Fogelsville, PANPI 1053303362
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.5%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Alcon accounts for 72.9% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $6,992 and has fallen 98.5% since, to $102 in 2025. Among retina specialist clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 28 payments — averaging $338.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$7K
- Cardinal Health 108 LLC$2K
- Astellas Pharma US Inc$353
- Regeneron Healthcare Solutions, Inc.$255
- Cardinal Health 110 LLC$150
- Genentech USA, Inc.$118
- plus $118 from 4 others
What the payments were for
- Consulting fees$1,72518%
- Speaking & faculty fees$4,50047%
- Travel & lodging$2,41425%
- Food & beverage$8449%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 2 | $6,914 |
| Cardinal Health 108 LLC | 1 | $1,575 |
| Astellas Pharma US Inc | 9 | $353 |
| Regeneron Healthcare Solutions, Inc. | 7 | $255 |
| Cardinal Health 110 LLC | 1 | $150 |
| Genentech USA, Inc. | 2 | $118 |
| AbbVie(2 entities) | 3 | $62 |
| Harrow Eye, LLC | 1 | $22 |
| Biogen | 1 | $19 |
| Apellis Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,483 in reported general payments places this provider in the 90th percentile of 43 retina specialist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 18 | $688 |
| Ketorolac Tromethamine | 12 | $178 |
Paid to pharmacies, not to this prescriber.
Other retina specialist in Fogelsville
- Joshua GreenePhiladelphia$394K
- Jay ChhablaniPittsburgh$70K
- Sachin PatelPottsville$17K
- Brian VanderbeekPhiladelphia$14K
- Christopher BairHermitage$9K
- Albert MaguirePhiladelphia$9K
- Hugo LinaresPhiladelphia$7K
- Moiz CarimWyomissing$6K
- Salman PorbandarwallaLancaster$6K
- Benjamin KimPhiladelphia$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.